SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Sol-Gel Technologies Ltd. (SLGL) News

Follow Sol-Gel Technologies Ltd. (SLGL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol SLGL Asset equity Sector Markets 90 days 2 Last 72.65 Updated Sep 17, 2026, 12:32 PM UTC Open live news feed Open SLGL chart & news
L SLGL - Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome SLGL - Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome NEWS | Sep 17, 2026, 12:32 PM UTC L Sol-Gel reports Q2 2026 financial results, issues corporate updates Sol-Gel (SLGL) reports its second quarter 2026 financial results and provides corporate updates, according to TradeXchange Newsdesk. EARNINGS | Aug 20, 2026, 12:32 PM UTC M SLGL: Mizuho Initiates Mizuho initiates coverage on Sol-Gel Technologies with an Outperform rating and a price target of $285 EQUITY | Jun 24, 2026, 10:13 AM UTC